Form 8-K - Current report:
SEC Accession No. 0001493152-21-031904
Filing Date
2021-12-17
Accepted
2021-12-17 17:22:58
Documents
18
Period of Report
2021-12-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38348
2 ex1-1.htm EX-1.1 257141
3 ex4-1.htm EX-4.1 129612
4 ex5-1.htm EX-5.1 12332
5 ex99-1.htm EX-99.1 12857
6 ex99-1_001.jpg GRAPHIC 3790
7 GRAPHIC ex5-1_001.jpg GRAPHIC 4370
  Complete submission text file 0001493152-21-031904.txt   728437

Data Files

Seq Description Document Type Size
8 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abeo-20211217.xsd EX-101.SCH 3043
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abeo-20211217_lab.xml EX-101.LAB 34240
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abeo-20211217_pre.xml EX-101.PRE 22371
11 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3609
Mailing Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 211502726
SIC: 2834 Pharmaceutical Preparations